Skip to content
  • About
  • Contact
  • Contribute
  • Book
  • Careers
  • Podcast
  • Recommended
  • Speaking
  • All
  • Physician
  • Practice
  • Policy
  • Finance
  • Conditions
  • .edu
  • Patient
  • Meds
  • Tech
  • Social
  • Video
    • All
    • Physician
    • Practice
    • Policy
    • Finance
    • Conditions
    • .edu
    • Patient
    • Meds
    • Tech
    • Social
    • Video
    • About
    • Contact
    • Contribute
    • Book
    • Careers
    • Podcast
    • Recommended
    • Speaking

Can the Ebola epidemic promote the development of medicine?

Chiduzie Madubata, MD
Conditions
August 31, 2014
Share
Tweet
Share

Having been born and raised in the United States, I have become accustomed to the reputation of the U.S. as being ahead of the curve in terms of advances in numerous fields including medicine, and the research that we produce in these fields strongly backs up this claim. I have been reminded of this over the past few days while following coverage of the Ebola outbreak in West Africa.

American health care providers in the region who caught the disease likely had their lives saved due to how prepared the U.S. was in terms of certain procedures that were put in place in order to treat them and prevent spread of the virus to the rest of the American public once they arrived in the States. It is the advanced understanding of infection control, the ability to develop new drugs, and the new discovery of how certain infections spread that put us at an advantage. It is this advantage that I encountered while training as a physician here, and it is an advantage that, with the appropriate resources, allows me the ability to treat a wide variety of patients, even if the disease may be rare. This exceptionalism in terms of the medical care we can provide in the U.S. brings about a sense of personal pride, and I felt that pride as I was hearing about the recovery of these providers due to the outstanding staff at the hospitals that received them.

But there is a conflicting emotion that also is in me as a person of Nigerian descent; it is a feeling of sadness as I see how the country of my ancestors is dealing with the epidemic. Even though the cases of Ebola in Nigeria are not as much as in other West African countries, it still struggles with lack of resources in the hospitals to adequate treat this type of epidemic. Lack of resources lead to inadequate care, and ultimately a higher death rate. Unfortunately, we are seeing it at full force as we see the governments in those countries struggle with how to contain the Ebola epidemic. Thankfully, the World Health Organization is trying to determine ways to deliver potential therapies to these countries, but time will be an issue. It takes time to make some of the vaccines that they are hoping to administer, and unfortunately time is not a luxury that some of these patients have. It underscores the importance of proximity to resources that are being developed.

Even in the U.S., proximity to particular medical resources can be a factor in terms of delivering adequate care for particular conditions in certain communities. Some places have more advanced capabilities than others, and depending on the distance, medical care may be delayed to certain communities unless adequate means to transfer patients to capable facilities are in place. Thankfully, this is not much of an issue in developed countries since reliable means of transport are readily available, and there are plenty of capable facilities in many parts of these countries.

Unfortunately, in the developing world, these luxuries may not be readily available. Transportation may be an issue, and even if transportation may be reliable, the centers that can deliver adequate care may be few and far between, leading to significant delays in care that could make the difference in whether a person survives a particular condition. Having spoken to friends who have rotated in clinics in the developing world, there are stories of patients who have died for lack of medications or other resources that are readily accessible in the U.S. and other developed countries. I can only imagine that this is a contributing factor in the rapid spread of the Ebola virus in West Africa, and it is tough to watch when I can easily take these medical resources for granted while I practice in the U.S.

My hope is that as more attention is brought to this epidemic, we become more aware of the disparities that exist between the developed and developing world in terms of medical care. The resources that exist in the U.S. should be more available in other countries, if anything to prevent the spread of potentially lethal infections like the one we are seeing in West Africa. With the numerous technological and scientific advancements made over the past few decades, more opportunities for sharing of ideas and resources are possible to help developing countries catch up in terms of ensuring better medical care for their citizens. We should not become accustomed to seeing many people die of disease due to lack of resources or scientific advancement, and accept that as the norm. My hope is that the same pride that I feel for the advances made in American health care over the years will be present as I hear stories of the advancement of health care in Nigeria, other countries in West Africa, and beyond.

Chiduzie Madubata is an internal medicine physician.

Prev

How many servings of fruits and vegetables should we eat a day?

August 30, 2014 Kevin 2
…
Next

Palliative care: A medical student's reflection

August 31, 2014 Kevin 3
…

Tagged as: Infectious Disease

Post navigation

< Previous Post
How many servings of fruits and vegetables should we eat a day?
Next Post >
Palliative care: A medical student's reflection

ADVERTISEMENT

More by Chiduzie Madubata, MD

  • The coronavirus cost that no one can count

    Chiduzie Madubata, MD
  • A physician sees end-of-life care through a religious lens

    Chiduzie Madubata, MD
  • Veterans deserve our full attention

    Chiduzie Madubata, MD

More in Conditions

  • Why Brooklyn’s aging population needs more vascular health specialists

    Anil Hingorani, MD
  • Why pediatricians are key to postpartum depression screening

    Mikenna Reiser
  • Prostate cancer genomic testing: a physician-patient’s perspective

    Francisco M. Torres, MD
  • Taiwan’s “Yi-Dong-Yang”: a preventive aging model for super-aged societies

    Gerald Kuo
  • What is palliative medicine and why is it so misunderstood?

    Patricia M. Fogelman, DNP
  • Physician suicide: a daughter-in-law’s story of loss and grief

    Carrie Friedman, NP
  • Most Popular

  • Past Week

    • A physician father on the Dobbs decision and reproductive rights

      Travis Walker, MD, MPH | Physician
    • Putting health back into insurance: the case for tobacco cessation

      Edward Anselm, MD | Policy
    • What is the minority tax in medicine?

      Tharini Nagarkar and Maranda C. Ward, EdD, MPH | Education
    • Will AI replace primary care physicians?

      P. Dileep Kumar, MD, MBA | Tech
    • Why every physician needs a sabbatical (and how to take one)

      Christie Mulholland, MD | Physician
    • Retail health care vs. employer DPC: Preparing for 2026 policy shifts

      Dana Y. Lujan, MBA | Policy
  • Past 6 Months

    • Why patient trust in physicians is declining

      Mansi Kotwal, MD, MPH | Physician
    • How environmental justice and health disparities connect to climate change

      Kaitlynn Esemaya, Alexis Thompson, Annique McLune, and Anamaria Ancheta | Policy
    • A physician father on the Dobbs decision and reproductive rights

      Travis Walker, MD, MPH | Physician
    • The blind men and the elephant: a parable for modern pain management

      Richard A. Lawhern, PhD | Conditions
    • Is tramadol really ineffective and risky?

      John A. Bumpus, PhD | Meds
    • Why insurance must cover home blood pressure monitors

      Soneesh Kothagundla | Conditions
  • Recent Posts

    • Silence is a survival mechanism that costs women their joy [PODCAST]

      The Podcast by KevinMD | Podcast
    • FDA loosens AI oversight: What clinicians need to know about the 2026 guidance

      Arthur Lazarus, MD, MBA | Policy
    • Why the U.S. health care system is failing patients and physicians

      John C. Hagan III, MD | Policy
    • Focusing on outcomes over novelty prevents AI failure in health care [PODCAST]

      The Podcast by KevinMD | Podcast
    • What is the minority tax in medicine?

      Tharini Nagarkar and Maranda C. Ward, EdD, MPH | Education
    • Putting health back into insurance: the case for tobacco cessation

      Edward Anselm, MD | Policy

Subscribe to KevinMD and never miss a story!

Get free updates delivered free to your inbox.


Find jobs at
Careers by KevinMD.com

Search thousands of physician, PA, NP, and CRNA jobs now.

Learn more

View 1 Comments >

Founded in 2004 by Kevin Pho, MD, KevinMD.com is the web’s leading platform where physicians, advanced practitioners, nurses, medical students, and patients share their insight and tell their stories.

Social

  • Like on Facebook
  • Follow on Twitter
  • Connect on Linkedin
  • Subscribe on Youtube
  • Instagram

ADVERTISEMENT

ADVERTISEMENT

  • Most Popular

  • Past Week

    • A physician father on the Dobbs decision and reproductive rights

      Travis Walker, MD, MPH | Physician
    • Putting health back into insurance: the case for tobacco cessation

      Edward Anselm, MD | Policy
    • What is the minority tax in medicine?

      Tharini Nagarkar and Maranda C. Ward, EdD, MPH | Education
    • Will AI replace primary care physicians?

      P. Dileep Kumar, MD, MBA | Tech
    • Why every physician needs a sabbatical (and how to take one)

      Christie Mulholland, MD | Physician
    • Retail health care vs. employer DPC: Preparing for 2026 policy shifts

      Dana Y. Lujan, MBA | Policy
  • Past 6 Months

    • Why patient trust in physicians is declining

      Mansi Kotwal, MD, MPH | Physician
    • How environmental justice and health disparities connect to climate change

      Kaitlynn Esemaya, Alexis Thompson, Annique McLune, and Anamaria Ancheta | Policy
    • A physician father on the Dobbs decision and reproductive rights

      Travis Walker, MD, MPH | Physician
    • The blind men and the elephant: a parable for modern pain management

      Richard A. Lawhern, PhD | Conditions
    • Is tramadol really ineffective and risky?

      John A. Bumpus, PhD | Meds
    • Why insurance must cover home blood pressure monitors

      Soneesh Kothagundla | Conditions
  • Recent Posts

    • Silence is a survival mechanism that costs women their joy [PODCAST]

      The Podcast by KevinMD | Podcast
    • FDA loosens AI oversight: What clinicians need to know about the 2026 guidance

      Arthur Lazarus, MD, MBA | Policy
    • Why the U.S. health care system is failing patients and physicians

      John C. Hagan III, MD | Policy
    • Focusing on outcomes over novelty prevents AI failure in health care [PODCAST]

      The Podcast by KevinMD | Podcast
    • What is the minority tax in medicine?

      Tharini Nagarkar and Maranda C. Ward, EdD, MPH | Education
    • Putting health back into insurance: the case for tobacco cessation

      Edward Anselm, MD | Policy

MedPage Today Professional

An Everyday Health Property Medpage Today
  • Terms of Use | Disclaimer
  • Privacy Policy
  • DMCA Policy
All Content © KevinMD, LLC
Site by Outthink Group

Can the Ebola epidemic promote the development of medicine?
1 comments

Comments are moderated before they are published. Please read the comment policy.

Loading Comments...